Search results
7 paź 2020 · “Two of the newly approved codes report nucleic acid assays that allow a single test to simultaneously detect the novel coronavirus and a combination of common viral infectious agents, including influenza A/B and respiratory syncytial virus,” said AMA President Susan R. Bailey, M.D. “Concurrent detection promises to conserve important ...
COVID-19 CDLT Flexibilities Fact Sheet. Commonly Ordered COVID-19, Influenza, and RSV Clinical Diagnostic Laboratory Tests for which Medicare Allows One Test Without a Practitioner Order During the PHE* Updated May 5, 2021. * When furnished simultaneously, one test from each of the first two categories (1. COVID-19; 2.
The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 & Flu A+B provides results for 3 different respiratory viruses (SARS-CoV-2 & Flu A, and Flu B) from one nasal specimen. With multiple testing modes and workflow efficiencies, the Analyzer is more versatile than ever.
The cobas® liat SARS-CoV-2, Influenza A/B & RSV assay for use on the cobas® liat system is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, influenza A, influenza B, and RSV in 20 minutes from a single nasal sample and in just one test.
The cobas ® SARS-CoV-2 & Influenza A/B test for use on the cobas® Liat® System provides urgent, accurate answers to rule-in or rule-out influenza and COVID-19 in 20 minutes from a single test, enabling early and effective patient care.
Results are for the identification and differentiation of RNA from SARS-CoV-2, Influenza A, Influenza B and RSV.
covid-19/flu a&b test is a lateral flow immuno-chromatographic assay which utilizes the chemical extraction of viral antigens followed by solid-phase immunoassay technology.
